February Publications from PharmaSafe

1. COVID-19 and Pregnancy: A European Study on Pre- and Post-Infection Medication Use

• Authors: Hurley E, Geisler BP, Lupattelli A, Poblador-Plou B, Lassalle R, Jové J, Bernard MA, Sakr D, Sanfélix-Gimeno G, Sánchez-Saez F, Rodríguez-Bernal CL, Sabaté M, Ballarín E, Aguilera C, Jordan S, Thayer D, Farr I, Ahmed S, Bartolini C, Limoncella G, Paoletti O, Gini R, Maglanoc LA, Dudukina E, Ehrenstein V, Alsina E, Vaz TA, Riera-Arnau J, Sturkenboom MCJM, Nordeng HME.
• This study, featured in the European Journal of Clinical Pharmacology, investigated medication usage among pregnant women with COVID-19 across six European regions. A significant increase in antithrombotic medication use post-infection was identified, especially in the second and third trimesters. These findings highlight potential implications for maternal and fetal health outcomes and underscore the necessity for further research in this area.

2. Impact of Genetic, Sociodemographic, and Clinical Features on Antidepressant Treatment Trajectories in the Perinatal Period

• Authors: Liu X, Trinh NT, Wray NR, Lupattelli A, Albiñana C, Agerbo E, Vilhjálmsson BJ, Bergink V, Munk-Olsen T.
• This study, published in the journal of European Neuropsychopharmacology, investigated the influence of genetic, sociodemographic, and clinical factors on antidepressant treatment patterns during the perinatal period among women with affective disorders.

3. Drug Utilisation in Children and Adolescents Before and After the Start of the COVID-19 Pandemic: Interrupted Time-Series Analyses in Three European Countries

• Authors: Pedersen E, Tripodi E, Aakjaer M, Li H, Cantarutti A, Nyberg F, Andersen M, Lupattelli A, Nordeng H
• This study, published in Paediatric and Perinatal Epidemiology, examined how the COVID-19 pandemic affected drug utilization among children and adolescents in Norway, Sweden, and Italy. The findings shed light on the impact of the pandemic on medication use in this population, particularly in relation to asthma medications and psychotropic medications among adolescents.

4. Partner Support for Women's Antidepressant Treatment and its Association with Depressive Symptoms in Pregnant Women, Mothers, and Women Planning Pregnancy

• Authors: Nasrin T, Tauqeer F, Bjørndal LD, Kittel-Schneider S, Lupattelli A
• This study, featured in Archives of Women's Mental Health, explored the association between partner support for women's antidepressant treatment and depressive symptoms in pregnant women, mothers, and women planning pregnancy.

These publications reflect the diverse research interests of our group and demonstrate our commitment to advancing knowledge in areas such as perinatal mental health, pediatric pharmacology, and the impact of social support on mental health outcomes.

Thank you to all of the researchers, collaborators, and supporters involved!

Stay tuned for more updates as we continue our exploration in health and medicine.